期刊文献+

免疫球蛋白检验在慢性乙型肝炎患者中的应用价值 被引量:9

Application value of immunoglobulin test in patients with chronic hepatitis B
下载PDF
导出
摘要 目的探究免疫球蛋白检验在慢性乙型肝炎患者中的应用价值。方法将2017年1月至2018年12月的400例慢性乙型肝炎患者设为试验组,同时选取400例健康体检者设为对照组。比较两组受检者的免疫球蛋白、总蛋白、白蛋白、ALT、GGT、AST、TBIL水平;比较轻度乙肝、中度乙肝、重度乙肝患者免疫球蛋白、ALT、GGT、AST、TBIL水平。结果试验组的IgG、IgA、IgM水平均显著高于对照组(P<0.05);试验组的总蛋白、白蛋白水平显著低于对照组(P<0.05)。试验组的ALT、GGT、AST、TBIL水平显著高于对照组(P<0.05)。中度乙肝、重度乙肝患者的IgG、IgA、IgM、ALT、GGT、AST、TBIL水平高于轻度乙肝患者,且重度乙肝患者高于中度乙肝患者(P<0.05)。结论免疫球蛋白检验能够反映慢性乙型肝炎患者的病情严重程度,可作为疾病确诊的辅助参考依据。 Objective To explore the application value of immunoglobulin test in patients with chronic hepatitis B.Methods From January 2017 to December 2018,400 patients with chronic hepatitis B were set as experimental group,while 400 healthy people were selected and set as control group.The levels of immunoglobulin,total protein,albumin,ALT,GGT,AST and TBIL were compared between the two groups;the levels of immunoglobulin,ALT,GGT,AST and TBIL in patients with mild,moderate and severe hepatitis B were compared.Results The levels of IgG,IgA and IgM in the experimental group were significantly higher than those in the control group(P<0.05);the levels of total protein and albumin in the experimental group were significantly lower than those in the control group(P<0.05).The levels of ALT,GGT,AST and TBIL of the experimental group were significantly higher than those of the control group(P<0.05).The levels of IgG,IgA,IgM,ALT,GGT,AST and TBIL in patients with moderate and severe hepatitis B were higher than those in patients with mild hepatitis B,and those in patients with severe hepatitis B were higher than those in patients with moderate hepatitis B(P<0.05).Conclusion Immunoglobulin test can reflect the severity of chronic hepatitis B patients,and can be used as an auxiliary reference for disease diagnosis.
作者 张云云 张琳 刘洁 芮晓静 ZHANG Yun-yun;ZHANG Lin;LIU Jie;RUI Xiao-jing(Affiliated Baoji Hospital of Xi'an Medical University,Baoji 721006,China)
出处 《临床医学研究与实践》 2020年第19期95-96,99,共3页 Clinical Research and Practice
关键词 免疫球蛋白 慢性乙型肝炎 肝硬化 immunoglobulin chronic hepatitis B cirrhosis
  • 相关文献

参考文献8

二级参考文献56

  • 1Jiang, Li,Yan, Lu-Nan.Current therapeutic strategies for recurrent hepatitis B virus infection after liver transplantation[J].World Journal of Gastroenterology,2010,16(20):2468-2475. 被引量:11
  • 2郭淑惠,王婧岚,宋育玲.乙肝疫苗与乙肝免疫球蛋白联用阻断HBV母婴传播[J].医药论坛杂志,2006,27(3):10-11. 被引量:5
  • 3吴正宏.高效乙肝免疫球蛋白联合乙肝疫苗阻断HBV母婴传播的效果观察[J].现代中西医结合杂志,2007,16(21):3010-3011. 被引量:1
  • 4Aqrawal RP, Sheroan V, Oia V, et al. Hepatocyte growth factor, diponectin and hepatic Q in non-alcoholic steatohepatitis[J]. J Assoc Physicians India,2013,61 (11):789-792.
  • 5Chenq X, Folco E J, Shimizu K, et al. Adi ponectin induces pro-inflammatory prog- rams in human macrophages and CD4+ T cells[J].J Biol Chem,2012,26:287-290.
  • 6Liu C J, Chen C J, Lai MY. High serum adiponectin correlates with advanced liver disease in patients with chronic hepatitis B virus infection[J]. Hepatol Int,2009,3(2): 364-370.
  • 7Esmaili S, Xu A, George J. The multifac- eted and controversial immunometabolic actions of adiponectin[J]. Trends Endocri- nol Metab,2014,2:1043 - 1047.
  • 8Jenke A, Holzhauser L, Lobel M, et al. Adiponectin promotes coxsackievirus B3 myocarditis by suppression of acute anti-- viral immune responses[J]. Basic Res Cardiol,2014,109(3):408-411.
  • 9Scotece M, Conde J, Lopez V, et al. Adi- ponectin and leptin: new targets in inflam- mation[J]. Basic Clin Pharmacol Toxicol, 2014,114(1):97-102.
  • 10Fantuzzi G. Adiponectin in inflammatory and immune-mediated diseases[J].Cytok- ine,2013,61(1):1-10.

共引文献84

同被引文献89

引证文献9

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部